GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells (Q34157062)

31 July 2017

GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells (English)

1 reference

31 July 2017

1 reference

1 reference

Dongmei Xiao

1

1 reference

PubMed ID

12409226

31 July 2017

Xiangping Qu

series ordinal

2

1 reference

PubMed ID

12409226

31 July 2017

H Christian Weber

series ordinal

3

1 reference

31 July 2017

1 November 2002

1 reference

31 July 2017

1 reference

31 July 2017

109

1 reference

31 July 2017

1-3

1 reference

31 July 2017

141-148

1 reference

Mammalian bombesin receptors

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Bombesin stimulation of fibroblast mitogenesis: specific receptors, signal transduction and early events

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Bombesin stimulation of c-fos and c-myc gene expression in cultures of Swiss 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

GRP-receptor-mediated signal transduction, gene expression and DNA synthesis in the human pancreatic adenocarcinoma cell line HPAF.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Bombesin induces c-fos and c-myc expression in quiescent Swiss 3T3 cells. Comparative study with other mitogens

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Bombesin stimulation of c-fos expression and mitogenesis in Swiss 3T3 cells: the role of prostaglandin E2-mediated cyclic AMP accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Bombesin stimulates growth of human prostatic cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

In situ hybridization for gastrin-releasing peptide receptor (GRP receptor) expression in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Calcium signaling in prostate cancer cells: evidence for multiple receptors and enhanced sensitivity to bombesin/GRP.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Signal transduction and the Ets family of transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

The ETS-domain transcription factor family

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Ets target genes: past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Neuroendocrine cells in tumour growth of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Neuroendocrine differentiation in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Neuroendocrine differentiation in prostatic malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Bombesin stimulates the in vitro growth of a human gastric cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Bombesin stimulation of mitogenesis. Specific receptors, signal transduction, and early events

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

Bombesin activates MAP kinase in non-small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

New insights into the control of MAP kinase pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2802%2900197-0

7 January 2021

10.1016/S0167-0115(02)00197-0

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12409226